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Scaffolds play a critical role in the engineering of functional tissues and organs; they provide 
the cells with a structure for forming the required living microenvironment. There are many 
apporaches for generating functional scaffolds. We recently pioneered the ability to directly 
electrospin living cells with a polymer containing many of the molecules found in native 
tissues. Those studies demonstrated that electrospinning cells did not cause any damage and 
subsequent investigations showed that cells maintain all their functions in vitro post-
treatment. In this communication we provide further evidence of the safety of this unique 
platform technology by demonstrating the in vivo viability of this direct cell scaffolding 
technology in a mouse model. These studies, together with our previous work, highlight cell 
electrospinning as a novel platform biotechnology for directly engineering functional pre-
organised three-dimensional tissues, as yet unrivalled by any other direct cell scaffolding 
approach.    
 
Fibrous architectures such as scaffolds have been explored in the area of tissue engineering 
and regenerative medicine for many years. [1] Although numerous investigations have 
demonstrated a wide range of scaffolds having utility in this endeavor, the use of scaffolds as 
substrates for cell seeding, for the creation of three-dimensional tissues/organs has been 
limited. These primary limitations stem from the inability to manually seed uniform quantities 
of cells over a given scaffold architecture, as well as poor and time dependent cellular 
infiltration into the scaffold (or throughout its entire depth), which ultimately restricts the 
possible movement of cells across the scaffold in three-dimensions. [2] Additionally these 
scaffold substrates present the seeded cells in two-dimension to those nutrients in three-
dimensions. These limitations have been partially overcome with the addition of another 
processing step into the living scaffold generation process, namely exploring ultrasonic 
agitation to the alternative stacking of cell sheets and scaffolds respectively, [3, 4] Although 
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such work has been successful using nutrient rich in vitro environments, this has not been 
demonstrated in vivo where nutrient availability is more variable. 
 
During embryo development, cell division and patterning in three dimensions leads to tissue 
and organ generation, with a continual process of remodeling occurring as development 
proceeds. [5] Hence our intention through our discovery of cell electrospinning was to capture 
native processes as closely as possible by combining cells with the biopolymer and the 
required molecules to provide all the constituents contained in native tissue, directly forming 
a living scaffold. Our previous studies using in vitro cell assays demonstrated that 
electrospinning cells did not produce any negative effects, which might prevent the cell 
functioning as expected when compared to untreated controls. In the work presented in this 
communication, previous in vitro work has been extended with in vivo experiments in the 
mouse followed over a time frame of nearly two weeks. This combination of in vitro and in 
vivo validation illustrates the significant promise this platform has in many areas of research 
and development, from basic biology, biotechnology and pharmaceuticals to the clinic. 
 
Cell electrospinning (CE) [6, 7] works on the principle of applying a high voltage through a DC 
source to a conducting coaxial needle system placed above a grounded collection grill or 
rotating mandrel. The coaxial needle system accommodates the flow of a cell suspension in 
the inner needle, while a low conducting high viscosity biopolymer flows through the outer 
needle (Figure 1A). The primary reason for exploring a coaxial needle system is based around 
its ability to utilize the properties of the biopolymer to shield the highly conducting cell 
suspension from the external electric field, which arises as a result of the electrodes. In 
addition this biopolymer also forms the matrix required for the cells. The properties of the 
biopolymer produce stability in the cell electrospinning process, which results in the 
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production of a continuous cell-bearing fiber, which over time forms a living scaffold or 
membrane. However cell electrospinning could be carried out in the single needle system in 
stable conditions by submerging the single needle in a cell-friendly biopolymer, which would 
provide a controlled atmosphere by which cell spinning would be achieved. [8]  
 
 
Figure 1. Schematic depiction of the two direct cell spinning approaches discussed in this 
article, A) cell electrospinning and B) aerodynamically assisted bio-threading. 
 
In these studies we also wished to explore another technology pioneered in 2007 [9, 10], namely 
aerodynamically assisted bio-threading (AABT – Figure 1B). This technology, which is not 
electric field-driven exploits a pressure drop over an exit orifice to produce a continuous 
polymer as a fiber, collection over time forms a scaffold and membrane. The novel advantage 
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of AABT over CE is that as a pressure drop drives the former, electrical conductivity of the 
cell suspension does not play a critical role, meaning a single needle could be used, with the 
cells mixed with a biopolymer (Figure 1B). Although their driving mechanisms are different 
their capabilities are very similar (Figure 2). One exception may arise when fiber alignment is 
required; cell electrospinning achieves this with the exploration of the electric field coupled 
with a given geometry for the grounded electrode. In the case of AABT a rotating mandrel 
could be used, as in CE, but physical movement of the mandrel would be required for cross 
stitching fibres in different directions. 
 
 
Figure 2. Living scaffold generated by way of cell electrospinning encapsulating GFP 
expressing N2A cells. Similar living architectures were generated by means of 
aerodynamically assisted bio-threading.  
1 mm 
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Figure 3. Characteristic optical micrographs of A, C, E, G and B, D, F, H of controls and CE 
samples respectively at a magnification of X4 for 0, 24, 48 and 72hrs post-treatment. Similar 
to the CE samples the AABT samples were indistinguishable from the controls. The scale bar 
in panel A represents 100µm and is applicable to all panels. 
  
Several samples of cellular scaffolds were collected from both CE and AABT preparations 
and incubated in culture media at 37oC and 5% CO2 initially for at least 30 minutes. The 
scaffolds were subsequently put into culture medium in Petri dishes until required for 
analysis. Post-incubation cells were recovered from at least five samples from each group, 
using either cell recovery or dispase. The recovered cells were assessed over 72hrs, analyzed 
phenotypically and labeled for flow cytometry (Figures 3 and 4). Our studies found that 
treated cells did not demonstrate any phenotypic alterations (Figure 3), and were 
indistinguishable from controls. Flow cytometry analysis showed similar cellular viability to 
our previous work. Staurosporine treatment led to cells undergoing apoptosis at 24hrs (Figure 
4B), as expected. Mitochondrial membrane potential was also analyzed over the same time 
course (Figure 4C), and correlated well with our previous in vitro work. Finally we used flow 
cytometry to analyse cellular proliferation over a shorter time course (4 to 24hrs post-
treatment), in order to understand whether cellular alterations took place just after treatment 
by either process. These studies show that the treatment processes have no effect on cell 
proliferation in comparison to controls (Figure 4D). Real-time in vivo bioluminescent imaging 
of mice implanted with control, CE and AABT tumour cells demonstrated that neither CE nor 
AABT treatments compromised the ability of the cells to proliferate in vivo; both treatment 
groups demonstrated similar tumour growth kinetics to the untreated control cells over the 
course of the experiment (Figure 5). 
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The studies reported here demonstrate that neither cell electrospinning (CE) nor 
aerodynamically assisted bio-threading (AABT) have any detectable effect on the in vitro or 
in vivo growth of the cells. This extends our previous investigations using bio-electrosprays 
and aerodynamically assisted bio-jets, which were also safe in terms of growth and survival of 
treated cells. Composite living structures have also been found to integrate post-transfer with 
their hosts without causing any form of rejection. These results increase our confidence in 
these bioplatform technologies, which we believe will have significant ramifications for the 
development of three-dimensional biological models, and could also contribute to the 
development of pre-orientated and organized architectures for repairing, replacing and 
rejuvenating damaged and/or ageing tissues, whilst also adding a novel approach to the 
delivery of biological therapeutics.  













C)        D) 
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Figure 4. Representative bar charts showing A) cellular viability of post-treated cells in 
comparison to controls over a time course of 72hrs [n=5, SD ±5%], B) cells subjected to 
staurosporine and analyzed at the time point of 24hrs, C) proportion of apoptotic cells as 
indicated by mitochondrial membrane potential of the three samples measured over 72hrs 
[n=3, SD ±3%] and D) cell proliferation of the three samples assessed at 0, 4 and 24hrs post-
treatment. Note in all panels the y-axis represents cellular percentage (%). 
 
Experimental Section 
The cells explored in these studies were mouse neuroblastoma cell line N2A, which have a 
high rate of proliferation and are able to form tumors in A/J mice. [11] These cells were 
cultured in Dulbecco’s modified eagle medium (DMEM) (with 10% fetal calf serum (FCS), 
1% non-essential amino acids, 1% sodium pyruvate and 1% penicillin/streptomycin) in tissue 
culture flasks and incubated at 37oC with 5% CO2. For real time in vivo imaging purposes, the 
luciferase gene was introduced into the N2A cells by way of a lentiviral system based on the 
LNT vector type, [12, 13] rendering the cells capable of bioluminescence. [13] The tagged cells 
were suspended in culture medium and incubated at 37oC with 5% CO2 until they were 
required for CE and AABT.  
 
The CE system explored in these studies used inner and outer needles with diameters in the 
ranges of ~800µm and ~2000µm respectively with both having a wall thickness of ~300µm. 
Collection took place with the aid of a fine wire mesh, which was submerged in DMEM 
approximatly 5mm and was maintained at 370C during fiber generation. During these cell 
electrospinning studies the electric field varied from 0.05-0.25 kV/mm. In the case of AABT 
the needle utilized was a ~1500µm single needle and collection was onto a similar mesh 
placed ~5mm below the surface of DMEM, which was maintained at 370C. The mesh 
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explored in these studies for collecting the genarated fibers/scaffolds had a square mesh 
configeration. Each induvidual mesh had the dimensions of ~6mm x 6mm with the mesh 
made with a wire having a thickness of ~1mm. The biopolymer used in both spinning 
scenarios was modified matrigel (BD Bioscience, Oxford, United Kingdom), which had a 
high concentration of laminin. Matrigel and modified versions have been explored previously 
with cells, for transfer into living hosts by way of intraperitoneal injection.[13, 14] Those studies 
have demonstrated that matrigel allows the efficient exchange of nutrients between the cells 
within the matrigel and its surrounding microenvironment through the matrix pores, without 
any alterations to the cell’s function. Samples were removed from the mesh and placed in 
Petri dishes containing Dulbecco’s modified eagle medium (DMEM) (with 10% fetal calf 
serum (FCS), 1% non-essential amino acids, 1% sodium pyruvate and 1% 
penicillin/streptomycin). The scaffold samples generated in these experiments were namely 1) 
untreated control N2A, 2) untreated luciferase expressing N2A cells, 3) CE-treated luciferase 
expressing N2A cells and 4) AABT-treated luciferase expressing N2A cells. Several living 
scaffold samples were generated for each of these groups. For in vitro and in vivo studies the 
cells were recovered using either cell recovery solution or dispase (BD Bioscience, Oxford, 
United Kingdom) [14, 15]. Breifly the cell recovery process was carried out by immersing the 
scaffold samples into either solution (cell recovery or dispase) which over ~15mins was seen 
to desolve and disassociate the cells from the scaffold. These cells were then centrifuged into 
a pellet and resuspensed in PBS (Phosphate Buffer Saline). The cells were washed three times 
in PBS before they were explored for in vitro and in vivo studies in these investigations. Prior 
to starting our flow analysis we phenotypically assessed the cells using a Leica phase contrast 
microscope over 72hrs (Figure 3).  
 
Submitted to  
 
 - 11 - 
For in vitro analysis we used flow cytometry to assess cell viability (Dead cell apoptosis kit, 
Life Technologies, V13242), mitochondrial membrane potential (Life Technologies, V35116) 
and cell proliferation (BD Biosciences, 347583). Assays were performed according to the 
manufacturer’s protocols and measured using a BD LSR II (Figure 4). In each case the flow 
cytometry measured over 20000 events. As a negative control we employed staurosporine 
(Invitrogen, PHZ1271), to inhibit a variety of kinases thereby triggering apoptosis (Figure 
3B). 
 
In vivo imaging of the treated cells transferred into mice was performed in accordance with 
the Animals Scientific Procedures Act (1986) and approved by the local Ethical Review 
Committee. Six to eight week-old A/J mice (Charles River UK Ltd) were used and 
anaesthetized by intraperitoneal injection of 50 mg kg-1 body weight ketamine (Ketaset; Fort 
Dodge Animal Health, Southampton, UK) and 5 mg kg-1 body weight xylazine (Rompun; 
Bayer, Newbury, Berkshire, UK) to conduct both cell implantation and real time 
bioluminescence imaging. Mice were subcutaneously implanted in the left flank with 5x104 
cells in a total volume of 100 µl. Tumor growth was assessed by bioluminescent imaging 
using an IVIS® Spectrum system (Caliper Life Sciences, Alameda, USA) which consists of a 
cooled charge-coupled device camera mounted on a light-tight specimen chamber. Mice were 
imaged 10-15 min after intraperitoneal injection of 300 mg kg-1 body weight D-luciferin 
mixed with the anesthetics. A grey scale reference image was taken under low illumination 
prior to quantification of emitted photons over 0.5 s to 2 min, depending on signal intensity, 
using the software program Living Image (Caliper Life Sciences). A pseudocolor image 
representing light intensity (blue, least intense to red, most intense) was generated using the 
Living Image software and superimposed over the grey scale reference image. 
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Bioluminescence within specific regions of individual mice was also quantified using the 
region of interest (ROI) tool in the Living Image software program (given as photons s-1).  
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Figure 5. (A) Real-time bioluminescent imaging of mice implanted with 5 x 104 untreated 
N2A cells (labeled as N2A), untreated luciferase-expressing N2A cells (labeled as N2A-Luc), 
cell-electrospun luciferase-expressing N2A cells (labeled as N2A-Luc, CE) or 
aerodynamically assisted bio-threaded luciferase-expressing N2A cells (labeled as N2A-Luc, 
AABT). 300 mg kg-1 body weight of D-luciferin mixed with ketamine and xylazine were 
administered by intraperitoneal injection 10–15 min prior to image acquisition. Mice were 
imaged at time points 1, 5, 9 and 13 days post-implantation. Images were obtained using an 
IVIS Spectrum and are displayed as pseudocolor images of peak bioluminescence (given as 
photons s-1 cm-2 sr-1), with variations in color representing light intensity at a given location. 
Note that the day 1 and day 5 images are shown at a different scale to day 9, and from day 13 
images. (B) Bioluminescence (given as photons s-1) in the left flank region was quantified 
using the Living image software. The values for each mouse are shown and the means and 
standard deviations were used to plot the graphs. A one-way ANOVA with Bonferroni 
B) 
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multiple comparison post-test (comparing all pairs of columns) for each time point, for N2A-
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Cell electrospinning and aerodynamically assisted bio-threading are novel bioplatforms 
for directly forming large quantities of cell-laden scaffolds for forming living sheets and 
vessels in three-dimensions. Functional biological architectures generated as those 
shown herein are most useful in both the laboratory and the clinic. 
 
Cell electrospinning and aerodynamically assisted bio-threading living cells 
 
Cell electrospinning an in vitro and in vivo study 
 
Samantha L. Sampson1, Luisa Saraiva2, Kenth Gustafsson2, Suwan N. Jayasinghe3 and Brian 
D. Robertson1  
 
 
 
 
 
 
 
 
